Cite
MLA Citation
Arvid Jungnik et al.. “Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906.” Diabetes, obesity & metabolism, vol. 25, no. 4, 2023, pp. 1011–1023. http://access.bl.uk/ark:/81055/vdc_100179871923.0x000021